| Jonathan T. Lord |
Jonathan T. Lord's current job(s) include being the Chairman at BIOLASE, Inc. since 2017, the Director at par8o LLC since 2014, and a Fellow at the College of American Pathologists. Dr. Lord's former job(s) include being the President & Chief Executive Officer at Life Technologies Clinical Services Lab, Inc. from 2009 to 2010, the Non-Executive Chairman at WFW Cardiac, Inc., the Chairman at DexCom, Inc. from 2010 to 2015, an Independent Director at Stericycle, Inc. from 2004 to 2014, a Director at NeuroMetrix, Inc. from 2006 to 2007, a Director at MAKO Surgical Corp. in 2013, a Director at Veracyte, Inc. from 2009 to 2013, a Director at Hubble Telemedical, Inc. from 2013 to 2014, a Director at Vigilant Biosciences, Inc. from 2013 to 2014, a Director at Digital Reasoning Systems, Inc., and a Director at Velano Vascular, Inc. Dr. Lord's education history includes an undergraduate degree from the University of Miami in 1978 and a doctorate from The University of Miami Leonard M. Miller School of Medicine. |
| Steven Sandor |
Steven Sandor is currently the Chief Operating Officer at BIOLASE, Inc. He started this position in 2022. He holds an MBA from Chapman University. |
| Richard R. Whipp |
Richard R. Whipp is currently the Vice President-Operations at BIOLASE, Inc. He previously worked as the Senior Director-Operations at Discus Dental LLC from 1998 to 2011 and as the Operations Director at Leica Geosystems, Inc. from 1992 to 1998. Mr. Whipp completed his undergraduate degree at Newark College of Engineering. |
| Samuel B. Low |
Samuel B. Low is currently the Vice President-Clinical Strategic Alliances at BIOLASE, Inc. and a Professor-Emeritus at the University of Florida. Previously, he served as an Independent Director at BIOLASE, Inc. from 2013 to 2014. He also held positions as a Trustee at the American Dental Association, President of the American Academy of Periodontology, and President of the Florida Dental Association, Inc. Dr. Low received his graduate degree from the University of Florida and his undergraduate, graduate, and doctorate degrees from the University of Houston. |
| Jennifer Brighton |
Jennifer Brighton is currently the Chief Financial Officer at BIOLASE, Inc. She previously worked as the Director & Controller at Avalara, Inc. from 2017 to 2018. Prior to that, she was the Accounting Director at Apria Healthcare, Inc. from 2009 to 2011. From 2005 to 2008, she served as the Controller at Richmond American Homes Corp. Jennifer also worked as the Controller at Crunch LLC from 2011 to 2016. Her most recent former position was as the Controller & Vice President-Accounting at Kellermeyer Bergensons Services LLC from 2018 to 2020. Ms. Brighton obtained her undergraduate degree from the University of Washington. |
| John R. Beaver |
John R. Beaver currently works at BIOLASE, Inc., as President, Chief Executive Officer & Director from 2021. Mr. Beaver also formerly worked at Pioneer Companies, Inc., as Vice President & Controller from 1997 to 2000, Sterling Chemicals, Inc., as Chief Financial Officer & Senior VP-Finance from 2007 to 2009, Sterling Chemicals, Inc., as Manager-Financial Reporting & Plant Accountant from 1987 to 1995, Silicor Materials, Inc., as Chief Financial Officer from 2015 to 2017, Modumetal, Inc., as Chief Financial Officer from 2013 to 2015, and Borden Chemicals & Plastics LP, as Controller from 1995 to 1997. Mr. Beaver received his undergraduate degree from The University of Texas at Austin. |
| Martha J. Somerman |
Martha J. Somerman is currently serving as an Independent Director at BIOLASE, Inc. She previously held the position of Director at the National Institutes of Health and the National Institute of Dental & Craniofacial Research from 2011 to 2019. Prior to that, she worked as a Professor at the University of Michigan School of Dentistry. Dr. Somerman obtained a doctorate degree from Rochester Christian University, a graduate degree from Hunter College, and an undergraduate degree from New York University. |
| Kenneth P. Yale |
Kenneth P. Yale is the founder of Advanced Health Solutions. He is currently an Independent Director at BIOLASE, Inc. His former jobs include Chief Executive Officer at Health Solutions Network LLC, Medical Director at Aetna, Inc., Executive Director-White House at Domestic Policy Council, Vice President-Government Programs at Matria Healthcare, Inc., Senior Vice President & General Counsel at Kaplan EduNeering, Inc., Chief of Staff at Office of Science & Technology Policy, Chief Clinical Officer at Delta Dental Insurance Co., Vice President at The Jefferson Group Ltd., and Vice President at CoRsolutions, Inc. He received his undergraduate degree from Creighton University, his doctorate from the University of Maryland, and another undergraduate degree from Georgetown University. |
| Jess Roper |
Jess Roper is an Independent Director at BIOLASE, Inc., a Director at Revelation Biosciences Sub, Inc., an Independent Director at Revelation Biosciences, Inc., and a Member at Corporate Directors Forum. Previously, Roper worked as a Controller & Finance Director at SeraCare Life Sciences, Inc., an Accounting Manager at Ngen, Inc., and an Auditor at PricewaterhouseCoopers LLP. Roper also served as the Chief Financial Officer & Senior Vice President at DexCom, Inc. Roper received undergraduate and graduate degrees from San Diego State University. |
| Kathleen T. O'Loughlin |
Kathleen T. O'Loughlin is an Independent Director at BIOLASE, Inc. She previously served as President & Chief Executive Officer at Dental Service of Massachusetts, Inc. and as Executive Director at American Dental Association from 2015 to 2021. She also served as a Trustee at Tufts University. Earlier in her career, she was the Chief Dental Officer at ThedaCare, Inc. from 2002 to 2008. Dr. O'Loughlin holds a graduate degree from Harvard University, an undergraduate degree from Boston University, and a doctorate from Tufts University. |
